Literature DB >> 7153507

Stool viruses in babies in Glasgow. 4. Further hospital studies.

C R Madeley, T M Scott, C Campbell, J Miller.   

Abstract

The events occurring during the time in hospital of 24 babies were recorded in detail, particularly those related to bowel function. The babies were admitted to a general paediatric unit with various diagnoses a total of 27 times during a six month period. The purpose of the study was to fill gaps in the records of a previous study (Scott et al. 1979) and to try to relate excretion of viruses detectable by electron microscopy to disturbances of bowel function (diarrhoea and/or vomiting). The results showed that a variety of viruses were associated with gastroenteropathy, that virus excretion could occur without disease and that hospital acquisition of virus is not uncommon. Antiobiotic treatment did not appear to precipitate diarrhoea in this small number of babies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153507      PMCID: PMC2134229          DOI: 10.1017/s0022172400070984

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  5 in total

1.  Stool viruses in babies in Glasgow 2. Investigation of normal newborns in hospital.

Authors:  C R Madeley; B P Cosgrove; E J Bell
Journal:  J Hyg (Lond)       Date:  1978-10

2.  Rotavirus infections in a maternity unit.

Authors:  B M Totterdell; I L Chrystie; J E Banatvala
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

3.  Stool viruses in babies in Glasgow. 3. Community studies.

Authors:  T M Scott; C R Madeley; B P Cosgrove; J P Stanfield
Journal:  J Hyg (Lond)       Date:  1979-12

4.  Stool viruses in babies in Glasgow. I. Hospital admissions with diarrhoea.

Authors:  C R Madeley; B P Cosgrove; E J Bell; R J Fallon
Journal:  J Hyg (Lond)       Date:  1977-04

5.  Role of viruses in febrile convulsions.

Authors:  H M Lewis; J V Parry; R P Parry; H A Davies; P J Sanderson; D A Tyrrell; H B Valman
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.